Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study.

Lansner J, Jensen CG, Petersen A, Fisher PM, Frokjaer VG, Vangkilde S, Knudsen GM.

Psychopharmacology (Berl). 2019 Jan 8. doi: 10.1007/s00213-018-5158-3. [Epub ahead of print]

PMID:
30623228
2.

Prompt but inefficient: nicotine differentially modulates discrete components of attention.

Vangkilde S, Bundesen C, Coull JT.

Psychopharmacology (Berl). 2011 Dec;218(4):667-80. doi: 10.1007/s00213-011-2361-x. Epub 2011 Jun 1.

3.

Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.

Low AM, Vangkilde S, le Sommer J, Fagerlund B, Glenthøj B, Jepsen JRM, Bundesen C, Petersen A, Habekost T.

Psychol Med. 2018 Dec 18:1-9. doi: 10.1017/S0033291718003628. [Epub ahead of print]

PMID:
30560740
5.

Effects of selective serotonin reuptake inhibition on neural activity related to risky decisions and monetary rewards in healthy males.

Macoveanu J, Fisher PM, Haahr ME, Frokjaer VG, Knudsen GM, Siebner HR.

Neuroimage. 2014 Oct 1;99:434-42. doi: 10.1016/j.neuroimage.2014.05.040. Epub 2014 May 22.

PMID:
24857827
6.

Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task.

Fitzpatrick CM, Caballero-Puntiverio M, Gether U, Habekost T, Bundesen C, Vangkilde S, Woldbye DP, Andreasen JT, Petersen A.

Psychopharmacology (Berl). 2017 Mar;234(5):845-855. doi: 10.1007/s00213-016-4520-6. Epub 2017 Jan 9.

PMID:
28070619
7.

Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.

Finke K, Dodds CM, Bublak P, Regenthal R, Baumann F, Manly T, Müller U.

Psychopharmacology (Berl). 2010 Jun;210(3):317-29. doi: 10.1007/s00213-010-1823-x. Epub 2010 Mar 30.

PMID:
20352415
8.

The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.

Wingen M, Kuypers KP, Ramaekers JG.

Psychopharmacology (Berl). 2007 Feb;190(3):391-400. Epub 2006 Nov 24.

PMID:
17124621
9.

Beyond time and space: The effect of a lateralized sustained attention task and brain stimulation on spatial and selective attention.

Shalev N, De Wandel L, Dockree P, Demeyere N, Chechlacz M.

Cortex. 2018 Oct;107:131-147. doi: 10.1016/j.cortex.2017.09.009. Epub 2017 Oct 3.

PMID:
29061290
10.

Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Foster RH, Goa KL.

CNS Drugs. 1997 Aug;8(2):163-88. doi: 10.2165/00023210-199708020-00010.

PMID:
23338224
11.

Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.

Ball SG, Ferguson MB, Martinez JM, Pangallo BA, Nery ES, Dellva MA, Sparks J, Zhang Q, Liu P, Bangs M, Goldberger C.

J Clin Psychiatry. 2016 May;77(5):635-42. doi: 10.4088/JCP.14m09619.

PMID:
27035159
12.
13.

The capacity of attention and simultaneous perception of objects: a group study of Huntington's disease patients.

Finke K, Schneider WX, Redel P, Dose M, Kerkhoff G, Müller HJ, Bublak P.

Neuropsychologia. 2007 Nov 5;45(14):3272-84. Epub 2007 Jun 26.

PMID:
17681560
14.

Dissociable spatial and non-spatial attentional deficits after circumscribed thalamic stroke.

Kraft A, Irlbacher K, Finke K, Kaufmann C, Kehrer S, Liebermann D, Bundesen C, Brandt SA.

Cortex. 2015 Mar;64:327-42. doi: 10.1016/j.cortex.2014.12.005. Epub 2014 Dec 30.

PMID:
25597524
15.

Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.

Loubinoux I, Tombari D, Pariente J, Gerdelat-Mas A, Franceries X, Cassol E, Rascol O, Pastor J, Chollet F.

Neuroimage. 2005 Aug 15;27(2):299-313.

PMID:
15950492
16.

Effects of monitoring for visual events on distinct components of attention.

Poth CH, Petersen A, Bundesen C, Schneider WX.

Front Psychol. 2014 Aug 21;5:930. doi: 10.3389/fpsyg.2014.00930. eCollection 2014.

17.

Parameter-Based Evaluation of Attentional Impairments in Schizophrenia and Their Modulation by Prefrontal Transcranial Direct Current Stimulation.

Gögler N, Papazova I, Oviedo-Salcedo T, Filipova N, Strube W, Funk J, Müller HJ, Finke K, Hasan A.

Front Psychiatry. 2017 Nov 29;8:259. doi: 10.3389/fpsyt.2017.00259. eCollection 2017.

19.

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ.

Psychopharmacology (Berl). 2004 Apr;172(4):400-8. Epub 2003 Dec 10.

PMID:
14666399
20.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A.

Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.

Supplemental Content

Support Center